newsfilter
← Latest News
GlobeNewswire·

Hepion Pharmaceuticals Expands SAB with Appointments of Four Liver Disease KOLs

EDISON, N.J., March 30, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence ("AI")-driven therapeutic drug development for